Ingcoy, Evelyn T.
HRN: 21-53-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/09/2022
07/16/2022
IV
1.5g
Q6
Infected Breast Mass, Left
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes